Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice

Myocardial infarction (MI) is a cardiovascular disease with high morbidity and mortality. Clinically, rehabilitation after massive MI often has a poor prognosis. Therefore, it is necessary to explore the therapeutic methods of myocardial protection after MI. As a first-line treatment for type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingyuan, Zou, Jiang, Wang, Jinjin, Liu, Meidong, Liu, Ke, Wang, Nian, Wang, Kangkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352811/
https://www.ncbi.nlm.nih.gov/pubmed/35950214
http://dx.doi.org/10.1016/j.omtn.2022.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352811/
https://www.ncbi.nlm.nih.gov/pubmed/35950214
http://dx.doi.org/10.1016/j.omtn.2022.07.009

Ejemplares similares